Internal Medicine, Cardiovascular Disease · Phoenix, AZ
NPI
1174623144
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3805 E Bell Rd, Suite 3100
Phoenix, AZ, 85032
Phone (602) 867-8644
Groups this clinician bills Medicare through
Medicare paid, 2024
$648K
5,186 services
Medicare patients, 2024
1,207
Average age 76
Drug cost, 2024
$1.6M
8,959 prescriptions
Company payments, 2025
$769
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kent Y Chen was code J2785 (injection, regadenoson, 0.1 mg), 884 times for 221 patients. In total Kent Y Chen billed 5,186 services in 36 codes, and Medicare paid $648K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 884 | 221 | $5.65 | $4,997 |
| 99214 Office E&M - Established | Office | 865 | 537 | $86.73 | $75K |
| 93000 Electrocardiogram | Office | 830 | 630 | $9.67 | $8,025 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 392 | 196 | $404.25 | $158K |
| 99233 Hospital E&M - Subsequent | Facility | 353 | 140 | $88.31 | $31K |
| 93306 Echocardiography (TTE/TEE) | Office | 295 | 287 | $127.04 | $37K |
| 99213 Office E&M - Established | Office | 278 | 244 | $57.95 | $16K |
| 93015 Electrocardiogram | Office | 260 | 260 | $50.56 | $13K |
| 78492 Myocardial Perfusion Scan | Office | 144 | 144 | $1,072.88 | $154K |
| 99232 Hospital E&M - Subsequent | Facility | 119 | 67 | $59.54 | $7,085 |
| 93306 Echocardiography (TTE/TEE) | Facility | 110 | 109 | $49.05 | $5,396 |
| 93793 Care Management/Coordination | Office | 98 | 23 | $7.74 | $758 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 98 | 49 | $26.44 | $2,591 |
| 99204 Office E&M - New | Office | 80 | 80 | $111.05 | $8,884 |
| 99215 Office E&M - Established | Office | 53 | 46 | $130.59 | $6,921 |
By year: 2022 $764K for 6,072 services; 2023 $807K for 5,772 services; 2024 $648K for 5,186 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kent Y Chen prescribed most often to Medicare patients was Metoprolol Succinate, with 1,355 prescriptions and refills. In total Kent Y Chen wrote 8,959 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,355 | 3,837 | 417 | $21K |
| Atorvastatin Calcium Generic | 997 | 2,928 | 324 | $8,752 |
| Eliquis Apixaban | 900 | 1,667 | 200 | $985K |
| Valsartan Generic | 726 | 2,067 | 215 | $24K |
| Lisinopril Generic | 446 | 1,281 | 143 | $3,318 |
| Furosemide Generic | 371 | 1,060 | 129 | $2,143 |
| Carvedilol Generic | 295 | 820 | 90 | $3,003 |
| Amlodipine Besylate Generic | 292 | 854 | 99 | $1,513 |
| Rosuvastatin Calcium Generic | 253 | 702 | 76 | $2,892 |
| Clopidogrel Clopidogrel Bisulfate | 251 | 733 | 80 | $2,727 |
| Potassium Chloride Generic | 247 | 688 | 87 | $4,920 |
| Nifedipine Er Nifedipine | 210 | 511 | 56 | $5,844 |
| Hydrochlorothiazide Generic | 200 | 585 | 65 | $745 |
| Metoprolol Tartrate Generic | 181 | 514 | 55 | $1,246 |
| Losartan Potassium Generic | 176 | 464 | 54 | $1,773 |
Brand drugs: 1,573 claims; generic drugs: 7,386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kent Y Chen $769 ($769 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $272.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $272 |
| Abbott Laboratories ABT | 1 | $140 |
| Pfizer Inc. PFE | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $109 |
| Novo Nordisk Inc NVO | 2 | $46.18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32.09 |
| Azurity Pharmaceuticals, Inc. | 1 | $28.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.